- Home
- WYY vs IMA Comparison
WYY vs IMA Comparison
Compare WYY & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WYY | IMA |
|---|---|---|
| Founded | 1991 | 2019 |
| Country | United States | United States |
| Employees | N/A | 15 |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.2M | 65.3M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | WYY | IMA |
|---|---|---|
| Price | $4.59 | $6.07 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | $8.67 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 44.0K | 32.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 54.35 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $142,571,749.00 | N/A |
| Revenue This Year | $5.20 | N/A |
| Revenue Next Year | $15.39 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 34.47 | N/A |
| 52 Week Low | $2.19 | $5.70 |
| 52 Week High | $7.55 | $17.50 |
Technical Indicators
Market Signals| Indicator | WYY | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 38.91 | 34.62 |
| Support Level | $3.96 | N/A |
| Resistance Level | $7.39 | $7.17 |
| Average True Range (ATR) | 0.38 | 0.37 |
| MACD | 0.05 | -0.09 |
| Stochastic Oscillator | 46.11 | 0.00 |
Price Performance
Historical ComparisonAbout WYY WidePoint Corporation
WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.